GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Inventurus Knowledge Solutions Ltd

IKS Health to acquire NASDAQ-listed TruBridge for $26.25 per share in Q3 2026

M&A ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 23 Apr 2026, 07:02 PM IST  ·  BSE ID: a3e16ebb-93ea-4324-af56-8bf540883288
View Original BSE Filing (PDF)
💡
In Simple Terms
IKS Health agreed to buy TruBridge, a US healthcare software company, for $26.25 cash per share. Deal closes later in 2026 if regulators and shareholders approve.
🤖 AI Summary
  • IKS Health to acquire NASDAQ-listed TruBridge for $26.25 cash per share, deal value undisclosed
  • Combined entity to serve 2,000+ healthcare organizations and 150,000+ clinicians post-closing
  • Closing expected Q3 2026 pending HSR clearance, shareholder approvals, and board satisfaction
  • IKS financing via term loan from Citibank, JPMorganChase, Deutsche Bank; subject to shareholder approval
  • TruBridge major shareholders Pinetree Capital, L6 Holdings, Ocho Investments commit 27% in support agreements
🔢 Key Numbers — exact figures from BSE filing, not rounded
TruBridge acquisition price per share
$26.25 cash
Combined entity healthcare organization coverage
2,000+ healthcare organizations
Combined entity clinician reach
150,000+ clinicians
TruBridge shareholder support voting commitment
27% of outstanding shares
Expected closing period
Q3 2026
🏢 How This Affects the Company
📈
Business Impact
Acquisition extends IKS Health's market reach into rural and community hospital segment. Combined entity serves 2,000+ healthcare organizations and 150,000+ clinicians across revenue cycle, EHR, and agentic AI solutions.
💰
Financial Impact
IKS will incur new indebtedness via term loan from Citibank, JPMorganChase, and Deutsche Bank to finance acquisition. Debt terms and acquisition cost per share confirm $26.25 cash payment, total enterprise value not disclosed in filing.
⚙️
Operational Impact
Post-closing integration will combine IKS Health's care enablement platform with TruBridge's revenue cycle management and EHR systems. Combined organization will deploy agentic AI workflows with human-in-the-loop expertise across ambulatory and acute care continuum.
⚠️
Risk Impact
Material regulatory risk: deal subject to Hart-Scott-Rodino notification and waiting period. Shareholder approval risk for both IKS Health and TruBridge. Integration execution risk for combined platform and customer retention.
👥 What This Means For Shareholders
✅
Action Required
IKS Health shareholders must vote to approve the acquisition and associated debt financing when shareholder meeting is announced.
👤
Who Is Affected
IKS Health and Inventurus Knowledge Solutions Limited shareholders will vote on acquisition approval and debt incurrence. TruBridge shareholders entitled to $26.25 per share upon closing, subject to TruBridge shareholder vote.
🔍
Management Signal
Management commits to expand rural healthcare market access and scale clinical-financial operations platform through strategic M&A in US healthcare technology.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
HSR Hart-Scott-Rodino approval notification — track for regulatory clearance status
IKS Health shareholder meeting announcement — required for debt financing and acquisition approval vote
TruBridge shareholder meeting results — required for deal closing conditional approval
Debt term sheet finalization from Citibank, JPMorganChase, Deutsche Bank — monitor leverage and rates
MEDIUM RISK Deal subject to HSR clearance, dual shareholder votes, and debt financing conditions. Regulatory approval uncertain; integration execution risk post-closing.
💡 Investor Takeaway
IKS Health acquires NASDAQ-listed TruBridge at $26.25 per share cash. Combined entity to serve 2,000+ healthcare organizations and 150,000+ clinicians. Financing via new debt. Closing Q3 2026 pending HSR and shareholder approvals. Exact deal value and debt terms not disclosed.
⚖️ Strengths & Concerns

✅ Positives

  • Large addressable market: combined entity serves 2,000+ healthcare organizations and 150,000+ clinicians
  • Strong shareholder support: major TruBridge shareholders controlling 27% committed via voting agreements

⚠️ Concerns

  • Deal contingent on multiple closing conditions: HSR clearance, shareholder votes, customary conditions
  • New debt financing required; terms, amount, and impact on leverage not disclosed in filing
📅 Company Track Record
IKS Health founded 2006, recognized by Black Book as top AI-driven RCM provider, KLAS-rated for performance and satisfaction. Inventurus Knowledge Solutions Limited listed NSE (IKS) and BSE (544309). Prior filing (Mar 2026) disclosed acquihire of ThinkDTM founder Bedi and AI team.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.